Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

作者: Andrea Pession , Riccardo Masetti , Carmelo Rizzari , Maria Caterina Putti , Fiorina Casale

DOI: 10.1182/BLOOD-2013-03-491621

关键词:

摘要: We evaluated the outcome of 482 children with acute myeloid leukemia (AML) enrolled in Associazione Italiana di Ematologia e Oncologia Pediatrica AML 2002/01 trial. Treatment was stratified according to risk group; hematopoietic stem cell transplantation (HSCT) used high-risk (HR)

参考文章(49)
Brenda E. S. Gibson, David K. H. Webb, Andrew J. Howman, Siebold S. N. De Graaf, Christine J. Harrison, Keith Wheatley, , Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial British Journal of Haematology. ,vol. 155, pp. 366- 376 ,(2011) , 10.1111/J.1365-2141.2011.08851.X
Y Perel, , A Auvrignon, T Leblanc, G Michel, Y Reguerre, J-P Vannier, J-H Dalle, V Gandemer, C Schmitt, F Méchinaud, O Lejars, C Piguet, G Couillaud, B Pautard, J Landman-Parker, I Thuret, N Aladjidi, A Baruchel, G Leverger, Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group. Leukemia. ,vol. 19, pp. 2082- 2089 ,(2005) , 10.1038/SJ.LEU.2403867
Martina Pigazzi, Elena Manara, Valeria Bisio, Sanja Aveic, Riccardo Masetti, Giuseppe Menna, Marco Zecca, Andrea Pession, Franco Locatelli, Giuseppe Basso, Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group. Blood. ,vol. 120, pp. 3860- 3862 ,(2012) , 10.1182/BLOOD-2012-09-454454
M Levis, D Small, FLT3: ITDoes matter in leukemia. Leukemia. ,vol. 17, pp. 1738- 1752 ,(2003) , 10.1038/SJ.LEU.2403099
Daisuke Tomizawa, Ken Tabuchi, Akitoshi Kinoshita, Ryoji Hanada, Hisato Kigasawa, Ichiro Tsukimoto, Masahiro Tsuchida, Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia : long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group Pediatric Blood & Cancer. ,vol. 49, pp. 127- 132 ,(2007) , 10.1002/PBC.20944
G. J.L. Kaspers, C. M. Zwaan, Pediatric acute myeloid leukemia: towards high-quality cure of all patients Haematologica. ,vol. 92, pp. 1519- 1532 ,(2007) , 10.3324/HAEMATOL.11203
Amy E. DeZern, Anthony Sung, Sharon Kim, B. Douglas Smith, Judith E. Karp, Steven D. Gore, Richard J. Jones, Ephraim Fuchs, Leo Luznik, Michael McDevitt, Mark Levis, Role of Allogeneic Transplantation for FLT3/ITD Acute Myeloid Leukemia: Outcomes from 133 Consecutive Newly Diagnosed Patients from a Single Institution Biology of Blood and Marrow Transplantation. ,vol. 17, pp. 1404- 1409 ,(2011) , 10.1016/J.BBMT.2011.02.003
F Locatelli, M Zecca, C Messina, R Rondelli, E Lanino, N Sacchi, C Uderzo, F Fagioli, V Conter, F Bonetti, C Favre, F Porta, G Giorgiani, A Pession, Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors Leukemia. ,vol. 16, pp. 2228- 2237 ,(2002) , 10.1038/SJ.LEU.2402690
Riccardo Masetti, Martina Pigazzi, Marco Togni, Annalisa Astolfi, Valentina Indio, Elena Manara, Rita Casadio, Andrea Pession, Giuseppe Basso, Franco Locatelli, CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype. Blood. ,vol. 121, pp. 3469- 3472 ,(2013) , 10.1182/BLOOD-2012-11-469825
Giorgio Dini, Marco Zecca, Adriana Balduzzi, Chiara Messina, Riccardo Masetti, Franca Fagioli, Claudio Favre, Marco Rabusin, Fulvio Porta, Erika Biral, Mimmo Ripaldi, Anna Paola Iori, Carla Rognoni, Arcangelo Prete, Franco Locatelli, None, No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission Blood. ,vol. 118, pp. 6683- 6690 ,(2011) , 10.1182/BLOOD-2011-05-354233